MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-02-0006964
Sanzyme Biologics Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹226.14 Cr
▲ 15% YoY
Net profit · FY 2025
₹53.05 Cr
Net margin 23.5%
EBITDA · FY 2025
₹90.36 Cr
EBITDA margin 40%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹1.67 Cr
Issued & subscribed
Satisfied charges
₹6.5 Cr
No open charges
Company age
10 yrs
Est. 2016
Employees · EPFO
461
Provident fund records
About Sanzyme Biologics Private Limited
Data last updated:
Sanzyme Biologics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the industrial enzymes and biochemicals segment of the chemicals and materials sector. It was incorporated on 16 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2016PTC112002. Its GSTIN is 36AAXCS6346M1ZC (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹1.67 Cr. It is led by directors including Raunak Jay Soman (Whole-Time Director) and Jay Soman.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹226.14 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹53.05 Cr (net margin 23.5%) and EBITDA of ₹90.36 Cr (EBITDA margin 40%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 12% over five years.
The company has about 461 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sanzyme Biologics. As per MCA filings, the company has satisfied charges of ₹6.5 Cr on record. Court records list 19 cases involving the company, including 17 filed by the company and 2 filed against it; 4 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹1.71 Cr; the latest was in March 2022.
Sanzyme Biologics Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0006964). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanzymebiologics.com.
Company details
CIN U24110TG2016PTC112002
Registration Number 112002
Incorporation Date 16 September 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0006964
Recognitions & Rankings of Sanzyme Biologics
Contact details
Sanzyme Biologics Private Limited's registered office is in Hyderabad, Telangana. Its website is sanzymebiologics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address2nd Floor Sattva Signature Tower, #8 – 2 – 472/1/A/B/Sf – 3 Road No. 1, Hyderabad, Telangana, India – 500034
- IndustryChemicals and Materials, Industrial Enzymes & Biochemicals
To see the full contact details of Sanzyme Biologics Private Limited, buy the company report.
Comprehensive company report
Sanzyme Biologics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sanzyme Biologics operates one associated brand: Sanzyme Biologics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces probiotic strains, enzymes, and supplements for health, pharma, and agriculture industries. | sanzymebiologics.com |
Business activity
The main business activity of Sanzyme Biologics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Sanzyme Biologics Private Limited, buy the company report.
Financials of Sanzyme Biologics Private Limited
FY 2024 filings availableSanzyme Biologics Private Limited reported revenue of ₹226.14 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹226.14 Cr ▲ 15%
Net profit · FY 2025
₹53.05 Cr margin 23.5%
EBITDA · FY 2025
₹90.36 Cr margin 40%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 11%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 3%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 15% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹90.36 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹53.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 40% | ||||
| Net Profit Margin | 23.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanzyme Biologics Private Limited, buy the company report.
Board of directors and KMP of Sanzyme Biologics Private Limited
Sanzyme Biologics Private Limited currently reports 3 directors and 1 key managerial person. 2 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raunak Jay Soman Also directs: Sanzyme Private Limited, Eila Life Sciences Private Limited | Whole-Time Director | 21 Oct 2017 | 9 Years 0 Months | Current |
| Dhruv Jay Soman Also directs: Sanzyme Private Limited, Eila Life Sciences Private Limited | Ceo | 14 Sep 2023 | 3 Years 1 Months | Current |
| Jay Soman Also directs: Plantus Private Limited, Sanzyme Private Limited | Director | 16 Sep 2016 | 10 Years 1 Months | Current |
| Surapaneni Sree Rama Koteswara Rao | Director | 16 Sep 2016 | 10 Years 1 Months | Current |
Auditor
Sanzyme Biologics Private Limited is audited by K.S. RAO & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.S. RAO & CO | FY 2023 | 003109S |
Shareholding
The shareholding of Sanzyme Biologics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sanzyme Biologics Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹6.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Apr 2018 | 100186783 | Others | ₹6.5 Cr | Satisfied |
To see the full charge records of Sanzyme Biologics Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Sanzyme Biologics Private Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹1.71 Cr; the latest was in March 2022.
Total deals
5
Secondary share transfers
4
Funding round
1
Disclosed funding
₹1.71 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Feb 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Oct 2017 | Funding round | ₹1.71 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sanzyme Biologics Private Limited has 19 court cases on record: 17 filed by Sanzyme Biologics, 2 filed against it. 4 cases are pending and 15 are disposed.
Total cases
19
Filed by the company
17
Filed against the company
2
Pending
4
Disposed
15
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 17 | 0 | 4 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Cosmas Research Lab Limited, Rep. by Mr. Punit Jain | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Vetrina Healthcare Pvt. Ltd | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Solistaa Pharmaceuticals Private Limited | Disposed |
| District court, Hyderabad Central, Telangana | Civil suit | Filed by the company against M/S. Rudra Bioventures Pvt Ltd | Disposed |
| District court, Hyderabad Central, Telangana | Civil suit | Filed by the company against M/S. Livein Aqua Solutions Pvt. Ltd., | Disposed |
To see the full case history of Sanzyme Biologics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Sanzyme Biologics Private Limited was last rated by Crisil on 25 Oct 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 25 Oct 2019 |
To see the full credit ratings and regulatory alerts of Sanzyme Biologics Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanzyme Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sanzyme Biologics Private Limited has a workforce of 461 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
461
Active EPFO establishments
1
Employee growth
16.4%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 461 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Sanzyme Biologics Private Limited, buy the company report.
GST
Sanzyme Biologics has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAXCS6346M1ZC | Telangana | Active | 09 Dec 2017 |
| 24AAXCS6346M1ZH | Gujarat | Active | 19 Dec 2017 |
To see the full GST registrations and return filing status of Sanzyme Biologics Private Limited, buy the company report.
Recent activity
Sanzyme Biologics Private Limited has 6 board changes on record since 2016: 4 appointments and 2 cessations. The latest: Dhruv Jay Soman was appointed as CEO on 14 Sep 2023.
AGM
Sanzyme Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sanzyme Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Dhruv Jay Soman was appointed as CEO.
Charges
A charge registered on 10 Apr 2018 via Charge ID 100186783 with Others was fully satisfied on 23 Jan 2023.
Charges
A charge with Others of Rs. 6.50 Cr registered on 10 Apr 2018 with Charge ID 100186783 was modified on 23 Sep 2022.
Ceased
Dhruv Jay Soman ceased to be Director.
Ceased
Raunak Jay Soman ceased to be Director.
Charges
A charge with Others amounted to Rs. 6.50 Cr with Charge ID 100186783 was registered on 10 Apr 2018.
Appointed
Raunak Jay Soman was appointed as Whole-Time Director.
Appointed
Jay Soman was appointed as Director.
Appointed
Surapaneni Sree Rama Koteswara Rao was appointed as Director.
Incorporation
16 Sep 2016
Sanzyme Biologics Private Limited was registered on 16 Sep 2016 with Roc Hyderabad & aged 10 years 1 month as per MCA records.
Frequently asked questions
Sanzyme Biologics is an active private limited company based in Hyderabad, Telangana, India. The company works in industrial enzymes and biochemicals, within the chemicals and materials industry. It was incorporated on 16 September 2016 (10+ years old) and is registered under CIN U24110TG2016PTC112002.
Sanzyme Biologics has 4 current directors and KMP:
- Raunak Jay Soman - Whole-Time Director
- Jay Soman - Director
- Surapaneni Sree Rama Koteswara Rao - Director
- Dhruv Jay Soman - Ceo
The latest financial statements of Sanzyme Biologics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Sanzyme Biologics is 36AAXCS6346M1ZC, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAXCS6346M1ZH (Gujarat).
The CIN (Corporate Identification Number) of Sanzyme Biologics is U24110TG2016PTC112002. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanzyme Biologics has 19 court cases on record: 17 filed by the company and 2 filed against it. 4 are pending. Most are in the district courts.
Sanzyme Biologics was incorporated on 16 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sanzyme Biologics has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹1.71 Cr; the latest was in March 2022.
Dhruv Jay Soman was appointed as CEO on 14 Sep 2023. Dhruv Jay Soman ceased to be Director on 24 Sep 2018. Raunak Jay Soman ceased to be Director on 24 Sep 2018. Sanzyme Biologics has 6 board changes on record in total.
Yes, Sanzyme Biologics is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0006964).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages